"OncoHolo: Spatial AI and Envoy3D, Redefining At-Home Cancer Care"

OncoHolo system, showcasing both the at-home device and the doctor’s office portal connected through secure cloud sharing for real-time health monitoring and collaborative care.

OncoHolo : Your At-Home Cancer Care Assistant

At-Home Device
“Monitor your health with ease and receive personalized guidance from HoloHealth’s conversational assistant, powered by ChatGPT. Track your wellness and stay informed with helpful alerts and insights.”

Doctor’s Portal
“Your doctor stays connected through HoloHealth’s secure portal, accessing real-time data and spatial insights generated by Envoy3D to support timely, informed care.”

Connected Through Secure Cloud Sharing
“OncoHolo ensures seamless, private data sharing between you and your healthcare team. Your doctor can view your progress, send advice, and offer personalized support without the need for an office visit.” 

Support for Cancer Patients, Right at Home
"OncoHolo connects you with your healthcare team, offering personalized insights and peace of mind throughout your cancer journey."

System and Method for Dynamic Tumor Microenvironment Modeling, Real-Time Precision Immunotherapy Adaptation, and EcDNA Tracking Using Digital Twins and Envoy3D

Patent ID-149089

Current approaches to cancer treatment, including immunotherapy, are limited by the static nature of traditional tumor profiling, which does not account for the dynamic evolution of the Tumor Microenvironment (TME) or real-time epigenetic changes such as extrachromosomal DNA (ecDNA). This invention introduces an advanced system for real-time cancer treatment adaptation, using Digital Twins to simulate individual patient TMEs and Envoy3D to model population-level responses. By tracking TME dynamics and ecDNA fluctuations, this system enables precision immunotherapy that can adapt to changes in the tumor’s genetic and immune profile, enhancing treatment efficacy and reducing resistance.

Summary of the Invention:

The invention provides a system and method for creating and continuously updating Digital Twins of a patient’s TME, integrating multi-omics data, spatial omics, and ecDNA profiling. These Digital Twins simulate tumor progression and predict responses to immunotherapy, adjusting treatment strategies in real time. Additionally, Envoy3D generates population-based Digital Cousins to identify treatment trends across similar TME types, aiding clinical decision-making and therapeutic development.

Patent ID-149089